🇺🇸 FDA
Pipeline program

TD-1211

0084

Phase 2 small_molecule completed

Quick answer

TD-1211 for Opioid Induced Constipation is a Phase 2 program (small_molecule) at Theravance Biopharma with 2 ClinicalTrials.gov record(s).

Program details

Company
Theravance Biopharma
Indication
Opioid Induced Constipation
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials